Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Lapatinib with Chemoradiation in Locally Advanced SCCHN
NCT00387127Phase 2Completed
- Sponsor
- GSK
- Start
- Nov 2006
- Primary completion
- Jun 2009
- Modality
- Small Molecules
- Countries
- 9
01
Overview
A Phase 2 trial of lapatinib in squamous cell carcinoma of the head and neck (HNSCC), sponsored by GSK. Started Nov 2006; status: completed.
02
Drugs
lapatinib
03
Conditions
squamous cell carcinoma of the head and neck (HNSCC)
Beyond the preview
Go deeper on NCT00387127.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00387127.